{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:48:31Z","timestamp":1785739711894,"version":"3.56.0"},"reference-count":34,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: CAV (cardiac allograft vasculopathy) is considered the leading cause of late post-transplant mortality and affects approximately 50% of transplant patients at 10 years post-transplant. Its etiopathogenetic mechanism is considered to be immune-mediated, but the identification of other non-immunological risk factors could represent new therapeutic targets for this pathology. Lipofuscin is due to reactive oxygen species (ROS) and appears to have a determining role in CAV. The aim of this study is to investigate the association between the amount of lipofuscin identified on EMB (endomyocardial biopsy) from patients followed up after heart transplantation, and the presence of CAV detected by coronary angiography. Methods: This retrospective study includes 99 EMBs from 47 transplanted patients, who also had coronary angiography. The amount of lipofuscin, damage to intramyocardial small vessels, vasculitis, Quilty effect, and acute cellular and humoral rejection was evaluated microscopically. Results: 19 CAV cases (19.2%) were identified, of which 15 (68.18% of total CAV cases) were insignificant. Grade 3 lipofuscin affected equally the cases with insignificant and significant CAV, 3 cases (37.5%) from each group. Grade 2 lipofuscin was reported in 10 cases (58.8%) of insignificant CAV, respectively 1 case of significant CAV (5.9%), (p-value of 0.0001). Quantitative evaluation of lipofuscin on microscopic sections revealed 8 EMBs (8.1%) with grade 3 lipofuscin. Two cases (25.0%) with lipofuscin score 3 were associated with moderate ACR (acute cellular rejection), ISHLT 2R and 3 cases (37.5%) with lipofuscin score 3 were associated with mild ACR ISHLT 1R, the differences being statistically significant, (p = 0.0001). Lipofuscin grades 2 and 3 were associated with severe fibrosis in 6 cases (35.3%) and 2 cases (25.0%), respectively (p = 0.042). A statistically significant association between the degree of damage to the intramyocardial small vessels and the amount of intracytoplasmic lipofuscin was observed (p = 0.00014). Discussion: Our study revealed that lipofuscin was more frequently associated with CAV, fibrosis, and damaged small vessels. Oxidative stress influences lipofuscinogenesis and CAV, which leads to endothelial dysfunction and neointimal hyperplasia, which over time will produce progressive narrowing of the vascular lumen and dysfunction of the cardiac allograft. Of the total number of 19 cases with CAV, 17 (89.47%) presented a lipofuscin score of 2 or 3 concomitantly with CAV, (p = 0.0001). This could mean that lipofuscin is not a harmless degradation product. At the same time, the association of a large number of cases with lipofuscin score 2, 10 cases (58.8%) with insignificant CAV could lead to the idea of using lipofuscin as a potential biomarker in the early diagnosis of CAV. Conclusions: We evidenced a significant association between the amount of intracytoplasmic lipofuscin and CAV. Accordingly, lipofuscin might be involved in the pathogenesis of CAV. Further research is needed to clarify the exact mechanisms of this association.<\/jats:p>","DOI":"10.3390\/diagnostics16152432","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:17:40Z","timestamp":1785737860000},"page":"2432","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipofuscin: Wear Pigment or Alarm Signal for Cardiac AlloGraft Vasculopathy?"],"prefix":"10.3390","volume":"16","author":[{"given":"Anca Otilia","family":"Farcas","sequence":"first","affiliation":[{"name":"Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania"},{"name":"Department of Cell Biology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai Ciprian","family":"Stoica","sequence":"additional","affiliation":[{"name":"Department of Nephrology\/Internal Medicine, Mures County Clinical Hospital, 540103 Targu Mures, Romania"},{"name":"Department of Internal Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Septimiu","family":"Voidazan","sequence":"additional","affiliation":[{"name":"Epidemiology Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6253-9309","authenticated-orcid":false,"given":"Carmen Corina","family":"Radu","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania"},{"name":"Institute of Forensic Medicine, 540141 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6574-2051","authenticated-orcid":false,"given":"Laszlo","family":"Hadadi","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, Emergency Institute for Cardiovascular Diseases and Transplantation Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liviu","family":"Gavrilovici","sequence":"additional","affiliation":[{"name":"Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horatiu","family":"Suciu","sequence":"additional","affiliation":[{"name":"Department of Surgery M3, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania"},{"name":"Emergency Institute for Cardiovascular Diseases and Transplantation Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Ileana","family":"Sin","sequence":"additional","affiliation":[{"name":"Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e045281","DOI":"10.1161\/JAHA.125.045281","article-title":"Beyond Rejection: Long-Term Survival Following Heart Transplant","volume":"14","author":"Chan","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kamel, M.A., Scalia, I.G., Badr, A.T., Baba Ali, N., Farina, J.M., Pereyra, M., Abbas, M.T., Mahmoud, A.K., Scott, R.L., and Steidley, D.E. (2024). Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.3390\/jcdd11030095"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.14797\/mdcvj.1580","article-title":"Cardiac Allograft Vasculopathy: A Focus on Advances in Diagnosis and Management","volume":"21","author":"Stomberski","year":"2025","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Farcas, A.O., Stoica, M.C., Voidazan, S., Maier, I.M., Maier, A.C., Suciu, H., and Sin, A.I. (2024). Histopathological Characteristics of Percutaneous Endomyocardial Biopsy in Heart Transplant Rejection Surveillance: A Single Center Experience. Biomedicines, 12.","DOI":"10.3390\/biomedicines12102258"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jtcvs.2009.02.040","article-title":"Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: Are they related to the development of cardiac allograft vasculopathy?","volume":"138","author":"Zakliczynski","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_6","unstructured":"Snyder, A.N., and Crane, J.S. (2026). Histology, Lipofuscin. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_7","first-page":"97","article-title":"Melanin and lipofuscin as hallmarks of skin aging","volume":"34","author":"Budzisz","year":"2017","journal-title":"Adv. Dermatol. Alergol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e20220313","DOI":"10.36660\/abc.20220313","article-title":"Cumulative Disorder of Myocardial Lipofuscin after Long-Term Heart Transplantation: A Study Based on Endomyocardial Biopsies","volume":"120","author":"Benvenuti","year":"2023","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J. Hear. Lung Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J. Hear. Lung Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"A9717","DOI":"10.1161\/circ.126.suppl_21.A9717","article-title":"Abstract 9717: The New ISHLT Cardiac Allograft Vasculopathy Coronary Angiogram Grading Scale: Does it Have Prognostic Relevance?","volume":"126","author":"Patel","year":"2012","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1111\/ajt.16083","article-title":"The XVth Banff Conference on Allograft Pathology the Banff Workshop Heart Report: Improving the diagnostic yield from endomyocardial biopsies and Quilty effect revisited","volume":"20","author":"Fedrigo","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/rej.2024.0034","article-title":"Toward Systemic Lipofuscin Removal","volume":"27","author":"Renteln","year":"2024","journal-title":"Rejuvenation Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-0716-4426-3_12","article-title":"Global Proteomic Profiling to Unravel Lipofuscin\u2019s Protein Repertoire","volume":"2906","author":"Thanos","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40035-025-00529-x","article-title":"Lipofuscin accumulation in aging and neurodegeneration: A potential \u201ctimebomb\u201d overlooked in Alzheimer\u2019s disease","volume":"14","author":"Dougnon","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"R\u00f3\u017canowska, M.B. (2023). Lipofuscin, Its Origin, Properties, and Contribution to Retinal Fluorescence as a Potential Biomarker of Oxidative Damage to the Retina. Antioxidants, 12.","DOI":"10.20944\/preprints202307.0304.v1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1039\/c9pp00406h","article-title":"Fluorescence characteristics of lipofuscin fluorophores from human retinal pigment epithelium","volume":"19","author":"Yakovleva","year":"2020","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103559","DOI":"10.1016\/j.redox.2025.103559","article-title":"Oxidized protein aggregate lipofuscin impairs cardiomyocyte contractility via late-stage autophagy inhibition","volume":"81","author":"Walter","year":"2025","journal-title":"Redox Biol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Smy\u0142a-Gruca, W., Szczurek-Wasilewicz, W., Skrzypek, M., Romuk, E., Karma\u0144ski, A., Jurkiewicz, M., G\u0105sior, M., Osadnik, T., Banach, M., and J\u00f3\u017awiak, J.J. (2024). Ceruloplasmin and Lipofuscin Serum Concentrations Are Associated with Presence of Hypertrophic Cardiomyopathy. Biomedicines, 12.","DOI":"10.3390\/biomedicines12081767"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.redox.2017.01.017","article-title":"Mitochondrial contribution to lipofuscin formation","volume":"11","author":"Ott","year":"2017","journal-title":"Redox Biol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sun, R., Zhu, B., Xiong, K., Sun, Y., Shi, D., Chen, L., Zhang, Y., Li, Z., and Xue, L. (2017). Senescence as a novel mechanism involved in \u03b2-adrenergic receptor mediated cardiac hypertrophy. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182668"},{"key":"ref_22","first-page":"282","article-title":"Aging of the myocardium and dilated cardiomyopathy: Morphological and molecular aspects","volume":"30","author":"Antonov","year":"2017","journal-title":"Adv. Gerontol."},{"key":"ref_23","first-page":"166205","article-title":"Analysis of cathepsin B and cathepsin L treatment to clear toxic lysosomal protein aggregates in neuronal ceroid lipofuscinosis","volume":"1867","author":"Marques","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.7150\/jca.86531","article-title":"The Role of Cathepsin B in Pathophysiologies of Non-tumor and Tumor tissues: A Systematic Review","volume":"14","author":"Wang","year":"2023","journal-title":"J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.bbapap.2007.07.004","article-title":"Proteomic analysis of cathepsin B- and L-deficient mouse brain lysosomes","volume":"1774","author":"Stahl","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.devcel.2025.02.004","article-title":"Mechanisms of ferroptosis sensitization and resistance","volume":"60","author":"Lee","year":"2025","journal-title":"Dev. Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4103\/1673-5374.358614","article-title":"Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration","volume":"18","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.7150\/ijbs.102859","article-title":"Mechanism of Ferroptosis and Its Role in Disease Development","volume":"21","author":"Ye","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104774","DOI":"10.1016\/j.cellimm.2023.104774","article-title":"Ferroptosis in the post-transplantation inflammatory response","volume":"393\u2013394","author":"Bai","year":"2023","journal-title":"Cell. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3892\/ijmm.2024.5457","article-title":"An emerging double-edged sword role of ferroptosis in cardiovascular disease (Review)","volume":"55","author":"Qin","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7436982","DOI":"10.1155\/2020\/7436982","article-title":"Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation","volume":"2020","author":"Szczurek","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Taraz\u00f3n, E., P\u00e9rez-Carrillo, L., Portol\u00e9s, M., and Rosell\u00f3-Llet\u00ed, E. (2022). Electron Microscopy Reveals Evidence of Perinuclear Clustering of Mitochondria in Cardiac Biopsy-Proven Allograft Rejection. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020296"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e009060","DOI":"10.1161\/CIRCIMAGING.119.009060","article-title":"Myocardial Fibrosis and Prognosis in Heart Transplant Recipients","volume":"12","author":"Hughes","year":"2019","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/15\/2432\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:35:46Z","timestamp":1785738946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/15\/2432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":34,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["diagnostics16152432"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16152432","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}